141 related articles for article (PubMed ID: 12847090)
21. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
22. Ets-1 protects vascular smooth muscle cells from undergoing apoptosis by activating p21WAF1/Cip1: ETS-1 regulates basal and and inducible p21WAF1/Cip: ETS-1 regulates basal and inducible p21WAF1/Cip1 transcription via distinct cis-acting elements in the p21WAF/Cip1 promoter.
Zhang C; Kavurma MM; Lai A; Khachigian LM
J Biol Chem; 2003 Jul; 278(30):27903-9. PubMed ID: 12740370
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy.
Algamas-Dimantov A; Yehuda-Shnaidman E; Peri I; Schwartz B
Cell Oncol (Dordr); 2013 Apr; 36(2):155-67. PubMed ID: 23307400
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21
Tseng TH; Chien MH; Lin WL; Wen YC; Chow JM; Chen CK; Kuo TC; Lee WJ
Environ Toxicol; 2017 Feb; 32(2):434-444. PubMed ID: 26872304
[TBL] [Abstract][Full Text] [Related]
25. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter.
Zhu WG; Srinivasan K; Dai Z; Duan W; Druhan LJ; Ding H; Yee L; Villalona-Calero MA; Plass C; Otterson GA
Mol Cell Biol; 2003 Jun; 23(12):4056-65. PubMed ID: 12773551
[TBL] [Abstract][Full Text] [Related]
26. Cladosporol a stimulates G1-phase arrest of the cell cycle by up-regulation of p21(waf1/cip1) expression in human colon carcinoma HT-29 cells.
Zurlo D; Leone C; Assante G; Salzano S; Renzone G; Scaloni A; Foresta C; Colantuoni V; Lupo A
Mol Carcinog; 2013 Jan; 52(1):1-17. PubMed ID: 22025467
[TBL] [Abstract][Full Text] [Related]
27. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.
Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF
Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219
[TBL] [Abstract][Full Text] [Related]
28. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells.
Xiao H; Hasegawa T; Isobe K
J Cell Biochem; 1999 Jun; 73(3):291-302. PubMed ID: 10321829
[TBL] [Abstract][Full Text] [Related]
29. Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb.
Bruno T; De Angelis R; De Nicola F; Barbato C; Di Padova M; Corbi N; Libri V; Benassi B; Mattei E; Chersi A; Soddu S; Floridi A; Passananti C; Fanciulli M
Cancer Cell; 2002 Nov; 2(5):387-99. PubMed ID: 12450794
[TBL] [Abstract][Full Text] [Related]
30. Transcription factor Sp1 mediates p38MAPK-dependent activation of the p21WAF1 gene promoter in vascular smooth muscle cells by pyrrolidine dithiocarbamate.
Moon SK; Jung SY; Kim CH
Biochem Biophys Res Commun; 2004 Apr; 316(3):605-11. PubMed ID: 15033443
[TBL] [Abstract][Full Text] [Related]
31. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter.
Zhang W; Geiman DE; Shields JM; Dang DT; Mahatan CS; Kaestner KH; Biggs JR; Kraft AS; Yang VW
J Biol Chem; 2000 Jun; 275(24):18391-8. PubMed ID: 10749849
[TBL] [Abstract][Full Text] [Related]
32. The SANT domain of human MI-ER1 interacts with Sp1 to interfere with GC box recognition and repress transcription from its own promoter.
Ding Z; Gillespie LL; Mercer FC; Paterno GD
J Biol Chem; 2004 Jul; 279(27):28009-16. PubMed ID: 15117948
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
Kim SN; Kim NH; Lee W; Seo DW; Kim YK
Mol Cancer Res; 2009 May; 7(5):735-44. PubMed ID: 19435809
[TBL] [Abstract][Full Text] [Related]
34. Human pituitary tumor transforming gene (hPTTG) inhibits human lung cancer A549 cell growth through activation of p21(WAF1/CIP1 ).
Mu YM; Oba K; Yanase T; Ito T; Ashida K; Goto K; Morinaga H; Ikuyama S; Takayanagi R; Nawata H
Endocr J; 2003 Dec; 50(6):771-81. PubMed ID: 14709851
[TBL] [Abstract][Full Text] [Related]
35. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
[TBL] [Abstract][Full Text] [Related]
36. Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells.
Nian H; Bisson WH; Dashwood WM; Pinto JT; Dashwood RH
Carcinogenesis; 2009 Aug; 30(8):1416-23. PubMed ID: 19528666
[TBL] [Abstract][Full Text] [Related]
37. Sodium butyrate inhibits cell growth and stimulates p21WAF1/CIP1 protein in human colonic adenocarcinoma cells independently of p53 status.
Kobayashi H; Tan EM; Fleming SE
Nutr Cancer; 2003; 46(2):202-11. PubMed ID: 14690797
[TBL] [Abstract][Full Text] [Related]
38. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.
Gartel AL; Ye X; Goufman E; Shianov P; Hay N; Najmabadi F; Tyner AL
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4510-5. PubMed ID: 11274368
[TBL] [Abstract][Full Text] [Related]
39. Evidence of a functional role for the cyclin-dependent kinase-inhibitor p21WAF1/CIP1/MDA6 in promoting differentiation and preventing mitochondrial dysfunction and apoptosis induced by sodium butyrate in human myelomonocytic leukemia cells (U937).
Rosato RR; Wang Z; Gopalkrishnan RV; Fisher PB; Grant S
Int J Oncol; 2001 Jul; 19(1):181-91. PubMed ID: 11408941
[TBL] [Abstract][Full Text] [Related]
40. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis.
Habold C; Poehlmann A; Bajbouj K; Hartig R; Korkmaz KS; Roessner A; Schneider-Stock R
J Cell Mol Med; 2008 Apr; 12(2):607-21. PubMed ID: 18419600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
